Notably, serum chemerin predicted short-term transplant-free mortality and correlated primarily with surrogates of impaired hepatic function and portal hypertension but not with extrahepatic organ failure, bacterial infection or the severity of systemic inflammation. This evidence concerns the gene RARRES2 and liver disorder.